Stay updated with breaking news from Modius Stress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neurovalens, a global leader in non-invasive neuro-technology, has appointed Kate Willis to oversee the sales of the belfast firms prescribed medical devices in the US
Neurovalens Ltd recently received U.S. FDA clearance for its Modius Stress device, a neurostimulator that treats people suffering from generalized anxiety disorder (GAD). It also closed a £2.1 million (US$2.65 million) funding round and is planning to raise up to $50 million in a series B fundraising round to be launched later this year.
The FDA has cleared Modius Stress, a medical device for the treatment of anxiety.
The FDA has cleared Modius Stress, a medical device for the treatment of anxiety.
News and commentary from the psychiatry world